Chronic Condition OTC Switches May Take Up To Seven Years – Consultant
This article was originally published in The Tan Sheet
Executive Summary
Clinical studies of Rx-to-OTC switch candidates that target chronic conditions may take 12-24 months longer to conduct than traditional study regimens for acute OTCs, consultant Robert Boggs, PhD, Waife & Associates, observes
You may also be interested in...
Rx-To-OTC “Switchability” Initiation Rights May Require Legislation – Juhl
Legislative action may be necessary to clarify who controls the Rx-to-OTC switch potential of a drug, University of Pittsburgh Vice Chancellor for Research Conduct & Compliance Randy Juhl, PhD, asserted
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands